search
Back to results

Clinical Trial of Multi-Periscopic Prism Glasses for Hemianopia

Primary Purpose

Homonymous Hemianopia

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Multi-Periscopic Prism (MPP) glasses
Fresnel Peripheral Prism (FPP) glasses
Sponsored by
Massachusetts Eye and Ear Infirmary
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Homonymous Hemianopia

Eligibility Criteria

7 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Homonymous hemianopia with or without macular sparing for at least 6 months
  • Visual acuity of at least 20/50 in each eye, with correction if needed
  • Refractive error in the -12D to +5D range
  • Able to walk independently, using a cane or walker if needed
  • Able to communicate in English sufficiently to understand the study procedures and how to use the prisms

Exclusion Criteria:

  • Central visual field loss in the seeing hemifield of either eye (e.g. from macular degeneration, glaucoma, diabetic retinopathy or other maculopathies)
  • Hemi-spatial neglect
  • Significant cognitive impairment
  • Dementia
  • Any other physical or mental disabilities, or general health problems that could impair the ability to be independently mobile (i.e., walk ), participate in the VR walking simulator test or use the prism glasses

Sites / Locations

  • UAB Center for Low Vision Rehabilitation, Callahan Eye HospitalRecruiting
  • UCHealth Sue Anschutz-Rodgers Eye CenterRecruiting
  • Visual Health and Surgical CenterRecruiting
  • Illinois College of OptometryRecruiting
  • Schepens Eye Research InstituteRecruiting
  • New England College of OptometryRecruiting
  • The Eye and Vision Center at MCPHS

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

MPP first, FPP second

FPP first, MPP second

Arm Description

Participants in this arm will receive the MPP in the first period of the crossover and the FPP in the second period.

Participants in this arm will receive the FPP in the first period of the crossover and the MPP in the second period.

Outcomes

Primary Outcome Measures

Change in detection rate for hazards approaching from the blind side in the VR walking simulator test
Number of pedestrians detected as a percentage of the total number of pedestrian events.

Secondary Outcome Measures

Change in detection response time for hazards approaching from the blind side in the VR walking simulator test
Response time from pedestrian target onset to the first button press to indicate detection
Device preference
Number of participants selecting each device as a percentage of the total number of participants enrolled
Continuation rate (at end of crossover)
Number of participants with a clinical decision to continue with prism glasses at the end of the crossover as a percentage of the total number of participants enrolled.
Continuation rate (long term)
Number of participants still wearing prism glasses as a percentage of total number of participants enrolled.

Full Information

First Posted
March 25, 2021
Last Updated
May 3, 2023
Sponsor
Massachusetts Eye and Ear Infirmary
Collaborators
National Eye Institute (NEI)
search

1. Study Identification

Unique Protocol Identification Number
NCT04827147
Brief Title
Clinical Trial of Multi-Periscopic Prism Glasses for Hemianopia
Official Title
Randomized Controlled Multicenter Clinical Trial of Multi-Periscopic Prism Glasses for Homonymous Hemianopia
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 3, 2022 (Actual)
Primary Completion Date
June 1, 2024 (Anticipated)
Study Completion Date
September 1, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Massachusetts Eye and Ear Infirmary
Collaborators
National Eye Institute (NEI)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This clinical trial will evaluate the efficacy of two types of high-power prism glasses that provide field of view expansion for patients with homonymous hemianopia (the complete loss of half the field of vision on the same side in both eyes).
Detailed Description
Patients with hemianopic field loss may be unaware of objects in their blind (non-seeing) hemi-field and often experience difficulties with hazards, such as walking into obstacles on the side of the field loss. Prism glasses that provide field of view expansion may be helpful in detecting hazards on the blind side. In this clinical trial, two types of high power prism glasses will be evaluated. A new design of prisms, Multi-Periscopic Prisms (MPP), will be compared to commercially-available permanent Fresnel peripheral prism (FPP) glasses. The extent to which the prismatic devices improve detection of hazards on the side of the field loss and are helpful when walking will be evaluated. Participants will try each type of prism glasses at home for 4 weeks in counterbalanced order. Prism glasses will be fitted by Low Vision Practitioners at vision rehabilitation clinics. Participants will attend in-office study visits before and after wearing each type of prism glasses. At the in-office visits they will complete a test that involves detecting pedestrian hazards in a video simulating a walk through a busy shopping mall (virtual reality, VR, walking simulator test). In addition, they may be asked to complete questionnaires to record their experiences of using the prism glasses. After wearing the second pair of prism glasses, participants will be asked to complete a questionnaire comparing the two types of prism glasses and to select their preferred type. A clinical decision will be made as to whether the participant should continue to use either the first or second pair of prism glasses (e.g. if a participant finds one pair of prism glasses helpful for obstacle avoidance when walking). For participants who continue with the prism glasses, telephone follow-up interviews will be conducted after about 6 and 12 months.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Homonymous Hemianopia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
65 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
MPP first, FPP second
Arm Type
Experimental
Arm Description
Participants in this arm will receive the MPP in the first period of the crossover and the FPP in the second period.
Arm Title
FPP first, MPP second
Arm Type
Experimental
Arm Description
Participants in this arm will receive the FPP in the first period of the crossover and the MPP in the second period.
Intervention Type
Device
Intervention Name(s)
Multi-Periscopic Prism (MPP) glasses
Intervention Description
Spectacles with multi-periscopic prisms mounted as oblique peripheral prism segments
Intervention Type
Device
Intervention Name(s)
Fresnel Peripheral Prism (FPP) glasses
Intervention Description
Spectacles with conventional permanent Fresnel prisms mounted as oblique peripheral prism segments
Primary Outcome Measure Information:
Title
Change in detection rate for hazards approaching from the blind side in the VR walking simulator test
Description
Number of pedestrians detected as a percentage of the total number of pedestrian events.
Time Frame
Baseline, After 4 weeks of wearing first pair of prism glasses, After 4 weeks of wearing second pair of prism glasses
Secondary Outcome Measure Information:
Title
Change in detection response time for hazards approaching from the blind side in the VR walking simulator test
Description
Response time from pedestrian target onset to the first button press to indicate detection
Time Frame
Baseline, After 4 weeks of wearing first pair of prism glasses, After 4 weeks of wearing second pair of prism glasses
Title
Device preference
Description
Number of participants selecting each device as a percentage of the total number of participants enrolled
Time Frame
After 4 weeks of wearing the second pair of prism glasses
Title
Continuation rate (at end of crossover)
Description
Number of participants with a clinical decision to continue with prism glasses at the end of the crossover as a percentage of the total number of participants enrolled.
Time Frame
After 4 weeks of wearing the second pair of prism glasses
Title
Continuation rate (long term)
Description
Number of participants still wearing prism glasses as a percentage of total number of participants enrolled.
Time Frame
At 6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
7 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Homonymous hemianopia with or without macular sparing for at least 6 months Visual acuity of at least 20/50 in each eye, with correction if needed Refractive error in the -12D to +5D range Able to walk independently, using a cane or walker if needed Able to communicate in English sufficiently to understand the study procedures and how to use the prisms Exclusion Criteria: Central visual field loss in the seeing hemifield of either eye (e.g. from macular degeneration, glaucoma, diabetic retinopathy or other maculopathies) Hemi-spatial neglect Significant cognitive impairment Dementia Any other physical or mental disabilities, or general health problems that could impair the ability to be independently mobile (i.e., walk ), participate in the VR walking simulator test or use the prism glasses
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Alex Bowers, PhD
Phone
617-912-2512
Email
alex_bowers@meei.harvard.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Eli Peli, OD MSc
Organizational Affiliation
Schepens Eye Research Institute of Massachusetts Eye and Ear
Official's Role
Principal Investigator
Facility Information:
Facility Name
UAB Center for Low Vision Rehabilitation, Callahan Eye Hospital
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35233
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dawn DeCarlo
Phone
205-325-8114
Email
ddecarlo@uabmc.edu
Facility Name
UCHealth Sue Anschutz-Rodgers Eye Center
City
Denver
State/Province
Colorado
ZIP/Postal Code
80045
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
David Simpson
Email
david.simpson@cuanschutz.edu
Facility Name
Visual Health and Surgical Center
City
Palm Springs
State/Province
Florida
ZIP/Postal Code
33461
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Scott Hearing
Phone
561-964-0707
Email
mrhearing@cs.com
Facility Name
Illinois College of Optometry
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60616
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tracy Matchinksi
Phone
312-949-7252
Email
TMatchin@ico.edu
Facility Name
Schepens Eye Research Institute
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02114
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alex Bowers
Phone
617-912-2512
Email
alex_bowers@meei.harvard.edu
Facility Name
New England College of Optometry
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02215
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jem Martin
Phone
617-587-5577
Email
martinj@neco.edu
Facility Name
The Eye and Vision Center at MCPHS
City
Worcester
State/Province
Massachusetts
ZIP/Postal Code
01608
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kathryn Deliso
Phone
508-373-5830
Email
Kathryn.deliso@mcphs.edu

12. IPD Sharing Statement

Learn more about this trial

Clinical Trial of Multi-Periscopic Prism Glasses for Hemianopia

We'll reach out to this number within 24 hrs